{"nct_id":"NCT02638103","title":"Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2016-02-26","start_date_type":"ACTUAL","primary_completion_date":"2018-06-06","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}